Lexicon Pharmaceuticals (LXRX)
(Delayed Data from NSDQ)
$1.66 USD
-0.03 (-1.78%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $1.65 -0.01 (-0.60%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Earnings News For LXRX
-
Lexicon Pharmaceuticals (LXRX) Reports Q2 Loss, Misses Revenue Estimates
-
Lexicon: Q2 Earnings Snapshot
-
Lexicon Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update
-
Lexicon Pharmaceuticals (LXRX) Reports Q1 Loss, Misses Revenue Estimates
-
Lexicon: Q1 Earnings Snapshot
-
Lexicon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
-
Lexicon: Q4 Earnings Snapshot
-
Lexicon Pharmaceuticals (LXRX) Reports Q4 Loss, Tops Revenue Estimates
-
Lexicon Pharmaceuticals Reports Fourth Quarter 2023 Financial Results and Provides Business Update
-
Analysts Estimate Lexicon Pharmaceuticals (LXRX) to Report a Decline in Earnings: What to Look Out for
-
Lexicon: Q3 Earnings Snapshot
-
Lexicon Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Update
-
Lexicon Pharmaceuticals (LXRX) Reports Q2 Loss, Tops Revenue Estimates
-
Lexicon Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business Update
-
Lexicon: Q1 Earnings Snapshot
-
Lexicon Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Business Update
-
Lexicon: Q4 Earnings Snapshot
-
Lexicon Pharmaceuticals Reports Fourth Quarter 2022 Financial Results and Provides Business Update
-
Lexicon: Q3 Earnings Snapshot
-
Lexicon Pharmaceuticals Reports Third Quarter 2022 Financial Results And Provides Business Update
-
Lexicon Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update
-
Lexicon Pharmaceuticals (LXRX) Reports Q2 Loss, Tops Revenue Estimates
-
Will Lexicon Pharmaceuticals (LXRX) Report Negative Q2 Earnings? What You Should Know
-
Lexicon Pharmaceuticals (LXRX) Reports Q1 Loss, Lags Revenue Estimates
-
Lexicon Pharmaceuticals (LXRX) May Report Negative Earnings: Know the Trend Ahead of Q1 Release